Resistance in oncolytic viral therapy for solid tumors

Prathibha Ambegoda-Liyanage and Sophia R.-J. Jang

Applied Mathematics and Computation, 2024, vol. 469, issue C

Abstract: Therapeutic resistance poses a significant obstacle in cancer control, and oncolytic viral therapy also faces the challenge of virus resistance. In this study, we propose models based on ordinary and delay differential equations to investigate the impact of resistance on tumor-virus interactions. The tumor cells are categorized as sensitive, resistant, or infected by oncolytic viruses. We show that if resistant tumor cells cannot be transformed into sensitive cells, every tumor cell will eventually acquire resistance. The model can possess at most one positive equilibrium, and we determine the critical delay magnitude beyond which the equilibrium becomes unstable. Our numerical simulations indicate that delays in the viral cycle can result in an increase in the total tumor burden. However, in terms of the overall tumor load, resistance may not be detrimental to the host if the delay in the viral cycle is substantial.

Keywords: Oncolytic viral therapy; Resistance; Volterra-Lyapunov stability; Hopf bifurcation (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0096300324000183
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:apmaco:v:469:y:2024:i:c:s0096300324000183

DOI: 10.1016/j.amc.2024.128546

Access Statistics for this article

Applied Mathematics and Computation is currently edited by Theodore Simos

More articles in Applied Mathematics and Computation from Elsevier
Bibliographic data for series maintained by Catherine Liu ().